Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial
Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check17 days agoChange DetectedThe page has undergone a version update from v2.14.4 to v2.15.0, and the mention of Principal Investigator Karen K Miller, MD from Massachusetts General Hospital has been removed.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
- Check89 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference3%
- Check96 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.2%
Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.